- CT1812 slowed cognitive decline by 95% in Alzheimer's disease patients with lower levels of plasma p-tau217 in a pre-specified analysis from Phase 2 SHINE study presented at CTAD - - On track to ...

CT1812 slowed cognitive decline by 95% in Alzheimer’s disease patients with lower levels of plasma p-tau217 in a pre-specified analysis from ...

Discover how traditional Chinese medicine is unlocking potential breakthroughs to dementia prevention and cognitive health.

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today ...

Ted Turner's colorful life is chronicled over six episodes on Max in a docuseries dubbed "Call Me Ted" out Nov. 13, 2024.

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients ...

Feeling sleepy and less enthusiastic during the day may indicate a higher risk of developing a syndrome that often leads to ...

These are available on the NHS. This type of medication is prescribed to people with mild symptoms of Alzheimer's or dementia with Lewy bodies. These are: donepezil (Aricept) rivastigmine (Exelon) ...

Attempts to discover a breakthrough dementia drug might be drawing attention these days, but traditional medicinal products ...

Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved ...